Trial Profile
A phase Ib trial of ZED 1227 for the treatment of celiac disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2017
Price :
$35
*
At a glance
- Drugs ZED 1227 (Primary)
- Indications Coeliac disease
- Focus Adverse reactions
- 02 May 2017 Status changed from recruiting to completed, according to a Zedira GmbH media release.
- 19 Jul 2016 New trial record